YS Biopharma Receives 180 Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Rule
納斯達克將YS Biopharma延期180天以恢復對最低出價規則的遵守
YS Biopharma Receives 180 Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Rule
納斯達克將YS Biopharma延期180天以恢復對最低出價規則的遵守
使用瀏覽器的分享功能,分享給你的好友吧